Document Type : Research articles

Authors

1 Department of Public Health, Sirjan School of Medical Sciences, Sirjan, Iran

2 Department of Nursing, Sirjan School of Medical Sciences, Sirjan, Iran

3 Research Committee, Department of Nursing, Sirjan School of Medical Sciences, Sirjan, Iran

Abstract

Background: Diabetes is a non-communicable disease with fatal complications. Diabetic patients are highly susceptible to COVID-19 side effects and persistent post-discharge symptoms that impact health-related quality of life (HRQoL).
Objectives: This study aimed to assess HRQoL and examine factors affecting diabetic and non-diabetic COVID-19 patients after hospitalization.
Methods: In a cross-sectional study, 220 diabetic and non-diabetic COVID-19 patients were randomly selected after hospitalization in Sirjan, Iran, from January 2020 to October 2021. The European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L) questionnaire was used to measure HRQoL as a dependent variable and its dimensions (including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) as independent variables. In addition, a checklist was used to identify determinants of HRQoL, including age, gender, education, family income, household ownership, occupation, number of family members, and access to health services, that might affect the HRQoL participants.
Results: The mean HRQoL score in COVID-19 diabetics (0.766±0.110) was significantly lower than that in their non-diabetic counterparts (0.859±0.077). The EQ-5D-5L scores in the diabetic group were significantly higher in younger participants, men, employed subjects, patients with higher educational levels, higher income, higher health status, supplemental insurance, access to health services, and fewer family members. According to the results of the Betamix model, education and diabetes were significant independent predictors of HRQoL scores.
Conclusion: Diabetic COVID-19 cases experienced a significant decrease in HRQoL after hospitalization. This drop might have been due to more side effects of COVID-19 in diabetic patients and lower utilization of health services during this period. It is suggested that the health sector changes the management of diabetics during the COVID-19 epidemic by taking measures such as using telemedicine, providing home services, or prescribing medications for a longer period.

Keywords

  1. Choi EP, Hui BP, Wan EY, Kwok JY, Tam TH, Wu C. COVID-19 and health-related quality of life: a community-based online survey in Hong Kong. Int J Environ Res Public Health. 2021;18(6):3228. doi: 10.3390/ijerph18063228. [PubMed: 33804725].
  2. Malik P, Patel C, Pinto C, Jaiswal R, Tirupathi R, Pillai S, et al. Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysis. J Med Virol. 2021;94(1):253-62. doi: 10.1002/jmv.27309. [PubMed: 34463956].
  3. Sandmann F, Tessier E, Lacy J, Kall M, Leeuwen EV, Charlett A, et al. Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARSCoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls. Clin Infect Dis. 2022;75(1):962-73. doi: 10.1093/cid/ciac151. [PubMed: 35245941].
  4. Kaso AW, Agero G, Hurisa Z, Kaso T, Ewune HA, Hailu A. Evaluation of health-related quality of life of Covid-19 patients: a hospital-based study in South Central Ethiopia. Health Qual Life Outcomes. 2021;19(1):1-10. doi: 10.1186/s12955-021-01900-y. [PubMed: 34930294].
  5. Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI, et al. Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review. Qual Life Res. 2021;30(12):3367-81. doi: 10.1007/s11136-021-02908-z. [PubMed: 34146226].
  6. Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020;14(3):211-2. doi: 10.1016/j.dsx.2020.03.002. [PubMed: 32172175].
  7. Feldman EL, Savelieff MG, Hayek SS, Pennathur S, Kretzler M, Pop-Busui R. COVID-19 and diabetes: a collision and collusion of two diseases. Diabetes. 2020;69(12):2549-65. doi: 10.2337/dbi20-0032. [PubMed: 32938731].
  8. Joensen LE, Madsen KP, Holm L, Nielsen KA, Rod MH, Petersen AA, et al. Diabetes and COVID‐19: psychosocial consequences of the COVID‐19 pandemic in people with diabetes in Denmark—what characterizes people with high levels of COVID‐19‐related worries?. Diabet Med. 2020;37(7):1146-54. doi: 10.1111/dme.14319. [PubMed: 32392380].
  9. Poudel AN, Zhu S, Cooper N, Roderick P, Alwan N, Tarrant C, et al. Impact of Covid-19 on health-related quality of life of patients: A structured review. PloS One. 2021;16(10):e0259164. doi: 10.1371/journal.pone.0259164. [PubMed: 34710173].
  10. Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-8. Doi: 10.15585/mmwr.mm6930e1. [PubMed: 32730238].
  11. Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using Open SAFELY. Nature. 2020;584(7821):430–6. doi: 10.1038/s41586-020-2521-4. [PubMed: 32640463].
  12. McDonald PE, Tilley BC, Havstad SL. Nurses’ perceptions: issues that arise in caring for patients with diabetes. J Adv Nurs. 1999;30(2):425-30. doi: 10.1046/j.1365-2648.1999.01096.x. [PubMed: 10457245].
  13. Vares ZM, Baghayi P, Masudi alavi N, Mirbagher ajorpaz N. Evaluation of quality of life and related factors in diabetic patients referred to the center of Kashan Diabetes. Nurs res. 2010;17(5):14-22.
  14. Mathers CD, Loncar D. Projections of global mortality
  15. and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi: 10.1371/journal.pmed.0030442. [PubMed: 17132052].
  16. International Diabetes Federation (IDF). IDF diabetes Atlas; 2019.
  17. Sadeghie Ahari S, Arshi S, Iranparvar M, Amani F, Siahpoosh H. The effect of complications of type II diabetes on patients’ quality of life. J Ardabil Univ Med Sci. 2009;8(4):394-402.
  18. Lee GK CJ, Bishop M. The effects of psychosocial factors on quality of life among individuals with chronic pain. Rehabil Couns Bull. 2008;51(3):177-89. doi: 10.1177/0034355207311318.
  19. Briggs A, Vassall A. Count the cost of disability caused by COVID-19. Nature. 2021;593(7860):502-5. doi: 10.1038/d41586-021-01392-2. [PubMed: 34040204].
  20. Abedini MR, Bijari B, Miri Z, Emampour FS, Abbasi A. The quality of life of the patients with diabetes type 2 using EQ-5D-5 L in Birjand. Health Qual Life Outcomes. 2020;18(1):18. doi: 10.1186/s12955-020-1277-8. [PubMed: 32000785].
  21. Dudzińska M, Zwolak A, Tarach JS. Quality of life in patients with type 2 diabetes in Poland-comparison with the general population using the EQ-5D questionnaire. Adv Clin Exp Med. 2015;24(1):139-46. doi: 10.17219/acem/38137. [PubMed: 25923098].
  22. Oemar M, Janssen B. EQ-5D-5 L user guide-basic information on how to use the EQ-5D-5 L instrument. Rotterdam: EuroQol Group; 2013.
  23. Alinia C, Yaghmaei S, Abdullah FZ, Ahmadi A, Samadi N, Pourteimour S, et al. The health-related quality of life in Iranian patients with COVID-19. BMC Infect Dis. 2021;21(1):459. doi: 10.1186/s12879-021-06170-z. [PubMed: 34016041].
  24. Arab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-related quality of life and its associated factors in COVID-19 patients. Osong Public Health Res Perspect. 2020;11(5):296-302. doi: 10.24171/j.phrp.2020.11.5.05. [PubMed: 33117634].
  25. Fernandes J, Fontes L, Coimbra I, Paiva J A. Health-related quality of life in survivors of severe COVID-19 of a university hospital in northern Portugal. Acta Med Port. 2021;34(9):601-607. doi: 10.20344/amp.16277. [PubMed: 34708687].
  26. Alimehr M, Malayen S, Vafa FS, Tahmasebi MJ, Nikbina M, Doostifar K. The impact of coronavirus disease (COVID-19) on quality of life in diabetic patients. Clin Diabetol. 2021;10(3):237-42.
  27. Ping WW, Zheng JZ, Niu XH, Guo CZ, Zhang JF, Yang H, et al. Evaluation of health-related quality of life using EQ-5D
  28. in China during the COVID-19 pandemic. PLoS One. 2020;15(6):e0234850. doi: 10.1371/journal.pone.0234850. [PubMed: 32555642].
  29. Nguyen HC, Nguyen MH, Do BN, Tran CQ, Nguyen TT, Pham KM, et al. People with suspected COVID-19 symptoms were more likely depressed and had lower health-related quality
  30. of life: the potential benefit of health literacy. J Clin Med. 2020;9(4):965. doi: 10.3390/jcm9040965. [PubMed: 32244415].
  31. Kastien-Hilka T, Rosenkranz B, Sinanovic E, Bennett B, Schwenkglenks S. Health -related quality of life in South African patients with pulmonary tuberculosis. PLoS One. 2017;12(4):e0174605. doi: 10.1371/journal.pone.0174605. [PubMed: 28426759].
  32. Yalachkov Y, Soydaş D, Bergmann J, Frisch S, Behrens M, Foerch C, et al. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis. Mult Scler Relat Disord. 2019;30:33–7. doi: 10.1016/j.msard.2019.01.049. [PubMed: 30735970].
  33. Malkova N, Riabukhina O, Babenko L, Ionova T, Kishtovich A. Health-related quality of life in patients with multiple sclerosis. Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(12):31–7. [PubMed: 16447564].
  34. Heiskanen S, Meriläinen P, Pietilä AM. Health-related quality of life–testing the reliability of the MSQOL-54 instrument among MS patients. Scand J Caring Sci. 2007;21(2):199–206. doi: 10.1111/j.1471-6712.2007. 00456.x. [PubMed: 17559438].
  35. Almeida V, Barrios S, Christl M, De Poli S, Tumino A, van der Wielen W. The impact of COVID-19 on households’ income in the EU. J Econ Inequal. 2021;19(3):413-31. doi: 10.1007/s10888-021-09485-8. [PubMed: 34093098].
  36. Eicher S, Pryss R, Baumeister H, Hövener C, Knoll N, Cohrdes C. Quality of life during the COVID-19 pandemic–Results of the CORONA HEALTH App study. J Health Monit. 2021;6(6):2-21. doi: 10.25646/8867. [PubMed: 35585992].